Has Panagiotis Valilis received payments from drug or device companies?

Yes. Drug and device makers reported $2,419 in general payments to Panagiotis Valilis across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Panagiotis Valilis did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Panagiotis Valilis come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Panagiotis Valilis

Hematology & Oncology · El Paso, TXNPI 1033158480

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,453 of the $2,419 with a category attached, or 60.1%. It is spread thinly across 16 manufacturers, the largest accounting for just 22.1%. Reporting peaked in 2019 at $1,138 and has fallen 63.4% since, to $416 in 2022. That places this record below the midpoint for hematology & oncology clinicians in TX, where the typical reported total is $3,204.

$2,419in general payments, 2019–2025

Across 34 payments — averaging $71.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$534
AstraZeneca$522
Rigel Pharmaceuticals, Inc.$250
Genentech USA, Inc.$190
E.r. Squibb & Sons, L.L.C.$178
Johnson & Johnson$169
plus $576 from 10 others

$129,587in research payments, 2019–2025

Across 13 payments — averaging $9968.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Amgen$124K
Novocure Inc.$6K

What the payments were for

Speaking & faculty fees$50021%
Food & beverage$1,45360%
Education$46619%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	3	$534
AstraZeneca(2 entities)	5	$522
Rigel Pharmaceuticals, Inc.	2	$250
Genentech USA, Inc.	3	$190
E.r. Squibb & Sons, L.L.C.	4	$178
Johnson & Johnson	2	$169
Astellas Pharma US Inc	2	$128
Gilead(2 entities)	2	$118
Amgen	2	$101
Takeda Pharmaceuticals U.S.A., Inc.	1	$86
Novartis	2	$35
Merck	2	$28
GSK	1	$24
Verastem, Inc.	1	$21
Karyopharm Therapeutics Inc.	1	$19
Seagen Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,419 in reported general payments places this provider in the 40th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas →

Other hematology & oncology in El Paso

Clifton LaymanEl Paso$645K
Warren AlexanderEl Paso$85K
Devesh PandyaHouston$1.8M
Elias JabbourHouston$1.3M
Asad DeanFort Worth$1.1M
Habte YimerTyler$934K
Edward PearsonDallas$900K
Naval DaverHouston$853K
Christopher MaiselDallas$713K
Jorge Cortes-FrancoHouston$627K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →